Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

Test Name
Optic Atrophy Gene Panel
Maximum Report Turnaround Time
30 days

What are the prerequisites for the test Optic Atrophy Gene Panel

  • Patients with suspected optic atrophy
  • Patients with a family history of optic atrophy
  • Patients with symptoms such as progressive vision loss, color vision defects, and optic nerve pallor
  • A signed consent form from the patient or guardian
  • A completed test requisition form

What are the measure values for the test Optic Atrophy Gene Panel

  • Gene Panel Name: Optic Atrophy Gene Panel
  • Measure Values:
    • OPA1 Gene: Positive/Negative
    • OPA3 Gene: Positive/Negative
    • WFS1 Gene: Positive/Negative
    • TMEM126A Gene: Positive/Negative
    • GFM1 Gene: Positive/Negative

What does this test Optic Atrophy Gene Panel identify?

  • Optic Atrophy Gene Panel identifies mutations in genes that are associated with optic atrophy, a group of disorders that affect the optic nerve and can result in vision loss.
  • These genes include OPA1, OPA3, WFS1, ACO2, and several others that are known to be involved in the maintenance of the optic nerve and visual function.
  • By analyzing these genes, the test can help in diagnosing the underlying genetic cause of optic atrophy and guiding treatment and management decisions.

Why is this test Optic Atrophy Gene Panel taken?

Reasons for Optic Atrophy Gene Panel Test

Reasons for Optic Atrophy Gene Panel Test

The Optic Atrophy Gene Panel test is taken for the following reasons:

  • Diagnosis: To help diagnose the cause of optic atrophy, which is a condition characterized by damage or degeneration of the optic nerve.
  • Risk assessment: To determine the risk of developing optic atrophy or passing it on to future generations.
  • Treatment decisions: To guide treatment decisions and management strategies for individuals with optic atrophy.
  • Genetic counseling: To provide information and support for individuals and families affected by optic atrophy.
  • Research: To contribute to ongoing research efforts aimed at understanding the genetic basis of optic atrophy and developing new treatments.

No FAQs available.

Customer Google Rating